CyTOF analysis of pretreatment and posttreatment samples
leukemia, AML, AML blasts
LEUKEMIA, AML
CyTOF was performed on patients in the AML cohort using paired pretreatment and cycle 1, day 2 samples (n = 11) and using pretreatment and cycle 1, day 21 samples (n = 16). We utilized UMAP analysis to dissect the leukemia proteomic landscape and identify AML blasts and healthy non-malignant cells in the leukemia compartment (Additional file 